NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Daisy Genomics

Daisy Genomics

Private
Albuquerque, New MexicoHealthcare & Life Scienceshttps://daisygenomics.com/

Last Round

Seed

Dec 17, 2025

Total Funding Raised

$8M

Company Overview

Daisy Genomics is a biotechnology company that develops a proprietary physics-based optical sequencing platform using nanochannels and surface-enhanced Raman spectroscopy (SERS) to detect DNA and RNA sequences for applications in precision medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Precision Medicine, Drug Discovery, Semiconductors

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Government Contracts

AI Layer

Infrastructure

Keywords

long-read sequencingepigenetic sequencingoptical sequencingsequencing platformlibrary-free sequencingprecision medicineSERSnanochannel sequencingsingle-molecule sequencingliquid biopsygenomic analysisnative DNA sequencingSurface Enhanced Raman Spectroscopyrazor and blade modelnanofluidicssequencing consumables

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Daisy Genomics Comps

Public and private peers based on sector, stage, and business model.

Daisy Genomics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Daisy Genomics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 17, 2025
GrantAug 31, 2022
Series BOct 18, 2021
SeedAug 16, 2017

Daisy Genomics Investors

Notable investors and investment history

Daisy Genomics investors
InvestorRounds
Sun Mountain CapitalSeries B
Cottonwood Technology FundSeed, Series B
Waves Capital PartnersSeed
Tramway Venture PartnersSeed, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 22, 2025

    Monthly visitors grew 58% MoM.

  • Oct 29, 2024

    Monthly visitors increased 54% MoM, reaching 2,000.

Daisy Genomics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Daisy Genomics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Daisy Genomics's valuation, stock price, and market status.

Firmographic Details

HeadquartersAlbuquerque, New Mexico
Employee Range6
Year Founded2015
Last FundingDec 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.